TSH (Thyroid Stimulating Hormone) is a key marker of thyroid function. In seniors, reference ranges shift upward: a TSH of 4–5 mU/L may be normal, whereas in younger adults it would indicate subclinical hypothyroidism. However, treatment of such mildly elevated levels is controversial. Large trials show no clear benefit of levothyroxine therapy in adults over 65 with subclinical hypothyroidism (TSH <10 mU/L) and no symptoms. Routine TSH screening in asymptomatic seniors is not recommended by major guidelines. Importantly, the MyBody-X Hormon & VitalCheck for Men does not measure TSH; it analyzes testosterone, cortisol, cholesterol, HbA1c, and PSA. For TSH assessment, a separate clinical blood test is required. Do not rely on DNA tests for thyroid diagnosis – they cannot reflect current hormone levels. If you experience symptoms like fatigue, weight changes, or cold intolerance, consult a physician. Evidence: The age-related shift in TSH reference ranges is well-established (human-strong); the benefit of treating subclinical hypothyroidism in the elderly is moderately supported (human-moderate).
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-1f33f561f0aa44ed5e24be1a